Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1591-9528
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia ; day:8 ; month:8 ; year:2022 ; pages:1-8
Clinical and experimental medicine ; (8.8.2022), 1-8
- Creator
-
Pálinkás, Márton
Szabó, Edit
Kulin, Anna
Mózner, Orsolya
Rásonyi, Rita
Juhász, Péter
Nagy, Krisztina
Várady, György
Vörös, Dóra
Zámbó, Boglárka
Sarkadi, Balázs
Poór, Gyula
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10238-022-00848-7
- URN
-
urn:nbn:de:101:1-2022102422184190111868
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pálinkás, Márton
- Szabó, Edit
- Kulin, Anna
- Mózner, Orsolya
- Rásonyi, Rita
- Juhász, Péter
- Nagy, Krisztina
- Várady, György
- Vörös, Dóra
- Zámbó, Boglárka
- Sarkadi, Balázs
- Poór, Gyula
- SpringerLink (Online service)
Other Objects (12)
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout
ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Susceptibility genes of hyperuricemia and gout
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Variation in serum urate levels in the absence of gout and urate lowering therapy
Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout
ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Susceptibility genes of hyperuricemia and gout
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Variation in serum urate levels in the absence of gout and urate lowering therapy
Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout
ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Susceptibility genes of hyperuricemia and gout
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Variation in serum urate levels in the absence of gout and urate lowering therapy
Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway